Formation of Biologically Active 13,14-Dihydro-Prostaglandin E1 During Intravenous Infusion of Prostaglandin E1 in Newborns With Ductus Arteriosus-Dependent Congenital Heart Disease.

British Journal of Clinical Pharmacology - United Kingdom
doi 10.1111/j.1365-2125.1992.tb04044.x
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

153 Prostaglandin E1 Infusion for Ductus Dependent Cardiac Lesions

Pediatric Research
Child HealthPediatricsPerinatology
1978English

Effects of Prostaglandin E1 Infusion in the Pre-Operative Management of Critical Congenital Heart Disease.

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
1985English

Prostaglandin E1 Therapy in Patients of Congenital Heart Disease With Pulmonary Atresia

The KITAKANTO Medical Journal
1994English

1152 Prostaglandin E1 Use in the Transfer of Infants With Suspected Duct Dependent Congenital Heart Disease

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2012English

Side Effects of Therapy With Prostaglandin E1 in Infants With Critical Congenital Heart Disease

Circulation
Cardiovascular MedicinePhysiologyCardiology
1981English

A Case of Non-Occlusive Mesenteric Ischemia Treated With Intravenous Infusion of Prostaglandin E1 and Enterectomy

The Journal of Kansai Medical University
2010English

Responsiveness of the Ductus Arteriosus to Prostaglandin E1 Assessed by Combined Cross-Sectional and Pulsed-Doppler Echocardiography

Journal of Cardiothoracic Anesthesia
1990English

Effect of Low-Dose Infusion of Prostaglandin E1 on Temperature Changes During Neurosurgical Anesthesia.

THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA
1992English

Clinical Study of Prostaglandin E1 in Peripheral Arterial Occulsive Disease

Juntendo Medical Journal
1984English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy